Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Toz: Suya kartrlarak kolayca iilebilir
Intranasal administration of a hematopoietic growth factor, which has limited capacity to cross the bloodbrain barrier, is 812 times more effective than subcutaneous application in brain and CSF delivery [83]
Power UP Get an Amazing Healthy Boost Now
*Correspondence: Xian-Feng Zhang, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A further 4 ml was slowly and carefully pipetted down the side of the tube to layer over the dissociated brain solution with minimal mixing of the layers
